Trophectoderm biopsy is associated with lower risks of moderate to extreme prematurity and low birthweights: a national registry cohort study of singleton livebirths from frozen-thawed blastocyst transfers - 20/11/24
, Trisha Shah, MD b, Haotian Wu, PhD c, Harry J. Lieman, MD a, d, Manvinder Singh, MD a, d, Staci Ellen Pollack, MD, MS a, Sangita Kathleen Jindal, PhD a, dAbstract |
Background |
Trophectoderm biopsy has become the mainstay assisted reproductive technique performed for preimplantation genetic testing, accounting for 43.8% of embryo transfer cycles in the United States in 2019 alone. Despite its prevalence, data on the obstetric and perinatal outcomes post-trophectoderm biopsy remains sparse and mixed.
Objective |
This study aimed to examine the risks of adverse perinatal outcomes in birthweights and prematurity after transfers of the vitrified-thawed blastocyst with trophectoderm biopsy for preimplantation genetic testing.
Study Design |
This was a retrospective observational cohort study of 45,712 singleton livebirths resulting from autologous vitrified-thawed blastocyst transfer cycles with or without trophectoderm biopsy for preimplantation genetic testing, reported by participating member clinics to the Society for Assisted Reproductive Technology national registry between 2014 and 2017. Adverse perinatal outcomes of preterm births and low birthweights were analyzed. Multivariable regression analyses were performed to control for covariates. Comparing the trophectoderm biopsy (n=21,584) and no trophectoderm biopsy (n=24,128) groups, adjusted odds ratios were calculated for the outcomes of small-for-gestational-age, large-for-gestational-age, low birthweight <2500 g, very low birthweight <1500 g, extremely low birthweight <1000 g, late preterm births <37 weeks, moderate preterm births <34 weeks, and extremely preterm births <28 weeks.
Results |
Women in the trophectoderm biopsy group were older and more likely to have prior pregnancies, deliveries, and a history of spontaneous abortions. Tobacco use, diminished ovarian reserve, and recurrent pregnancy loss were also more prevalent in the trophectoderm biopsy group. Trophectoderm biopsy was not associated with small-for-gestational-age (adjusted odds ratio, 0.97; 95% confidence interval, 0.85–1.12; P=.72) or large-for-gestational-age newborns (adjusted odds ratio, 1.10; 95% confidence interval, 0.99–1.22; P=.09). Risks of preterm births <37 weeks gestation were similar between the biopsy and nonbiopsy groups (adjusted odds ratio, 0.93; 95% confidence interval, 0.85–1.02; P=.11). Trophectoderm biopsy was associated with a significantly lower risk of low birthweight <2500 g (adjusted odds ratio, 0.80; 95% confidence interval, 0.70–0.92; P<.001), very low birthweight <1500 g (adjusted odds ratio, 0.62; 95% confidence interval, 0.46–0.83; P<.001), extremely low birthweight <1000 g (adjusted odds ratio, 0.48; 95% confidence interval, 0.31–0.74; P<.001), moderate preterm birth <34 weeks (adjusted odds ratio, 0.76; 95% confidence interval, 0.64–0.91; P=.003), and extreme preterm birth <28 weeks (adjusted odds ratio, 0.63; 95% confidence interval, 0.43–0.92; P=.02).
Conclusion |
Trophectoderm biopsy is not associated with increased risks of small-for-gestational-age, large-for-gestational-age, or late preterm birth. Risks of low birthweight, very low birthweight, and extremely low birthweight from moderate and extreme preterm births are lower after trophectoderm biopsy, possibly by selecting against confined placental mosaicism or inducing placental epigenetic changes, the mechanisms of which warrant further investigation.
Le texte complet de cet article est disponible en PDF.Key words : assisted reproductive technology, low birthweights, perinatal complications, preimplantation genetic testing, preterm births, trophectoderm biopsy, vitrified/frozen-thawed blastocyst transfer
Plan
| The authors report no conflict of interest. |
|
| Presented orally at the 79th annual meeting of the American Society for Reproductive Medicine Annual Scientific Congress, New Orleans, LA, Oct. 14–18, 2023. |
|
| Cite this article as: Liu AHC, Shah T, Wu H, et al. Trophectoderm biopsy is associated with lower risks of moderate to extreme prematurity and low birthweights: a national registry cohort study of singleton livebirths from frozen-thawed blastocyst transfers. Am J Obstet Gynecol 2024;231:636.e1-9. |
Vol 231 - N° 6
P. 636.e1-636.e9 - décembre 2024 Retour au numéro
Article précédent
- Dissecting the shared genetic architecture between anti-Müllerian hormone and age at menopause based on genome-wide association study
- Panpan Long, Hangjing Tan, Binbin Chen, Le Wang, Ruping Quan, Zihao Hu, Minghua Zeng, Jonathan Greenbaum, Hui Shen, Hongwen Deng, Hongmei Xiao
- Vasa previa in singleton pregnancies: diagnosis and clinical management based on an international expert consensus
- Yinka Oyelese, Ali Javinani, Brittany Gudanowski, Eyal Krispin, Andrei Rebarber, Ranjit Akolekar, Val Catanzarite, Rohan D’Souza, Richard Bronsteen, Anthony Odibo, Matthias A. Scheier, Junichi Hasegawa, Eric Jauniaux, Christoph Lees, Deepa Srinivasan, Elizabeth Daly-Jones, Gregory Duncombe, Yaakov Melcer, Ron Maymon, Robert Silver, Federico Prefumo, Daisuke Tachibana, Wolfgang Henrich, Robert Cincotta, Scott A. Shainker, Angela C. Ranzini, Ashley S. Roman, Ramen Chmait, Edgar A. Hernandez-Andrade, Daniel L. Rolnik, Waldo Sepulveda, Alireza A. Shamshirsaz
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?